Proposed takeover of AstraZeneca

Inquiry concluded

The Science and Technology Committee considered the potential impact on the UK science base of a merger between the pharmaceutical companies AstraZeneca and Pfizer in a one-off evidence hearing on Wednesday 14 May. The Committee took evidence from both companies and from the Minister for Universities and Science, David Willetts MP.